Rewrite University of Cincinnati structural biology research published in prestigious PNAS this news headline for the science magazine post

Two key protein structures in the body are being visualized for the first time, thanks in part to the latest technology in the University of Cincinnati’s Center for Advanced Structural Biology — potentially opening the door for better designed therapeutics.

The research of a trio of UC structural biologists was published today in the Proceedings of the National Academy of Sciences (PNAS).

It’s the first publication to come out of the Seegar Lab at UC. Tom Seegar, PhD, Ohio Eminent Scholar and assistant professor in the Department of Molecular and Cellular Biosciences in the College of Medicine, serves as corresponding author of the study.

.adsslot_D78BxWtj9h{width:728px !important;height:90px !important;}
@media(max-width:1199px){ .adsslot_D78BxWtj9h{width:468px !important;height:60px !important;}
}
@media(max-width:767px){ .adsslot_D78BxWtj9h{width:320px !important;height:50px !important;}
}

ADVERTISEMENT

The study’s first authors are Joe Maciag, PhD, a research scientist in the Seegar Lab, and Conner Slone, a graduate student assistant in the Seegar Lab.

They are “seeing” the physical, atomic structure of two protein structures for the first time, along with how they interact, which can alter their function, and how that drives inflammatory signaling.

“If you can see something, you can figure out how it works,” said Seegar. “We are figuring out what this enzyme looks like and how it’s regulated.”

What they saw

The Seegar Lab used advanced cryogenic electron microscopy techniques to visualize the structure of the ADAM17 enzyme bound to its regulator protein, iRhom2, and identify key elements vital for its activity. They were also able to highlight the essential interaction in the ADAM17-iRhom2 Complex that controls the processing of protein substrates.

Researchers know ADAM17 is a crucial enzyme present in every cell, necessary for proper development and immune regulation. They also know it becomes dysregulated in the immune systems of people with chronic inflammatory diseases and is linked to rheumatoid arthritis, cancer and Covid-19.

Now researchers are looking at the signals that ADAM17 sends to other proteins involved in immune defense and tissue repair. “We know in some cancers and rheumatoid arthritis, way too much signaling is occurring,” said Maciag. “But some treatments create too many side effects, worse than the disease itself.”

Maciag said researchers are now looking at how they can target iRhom2 for more selective therapeutic interventions. They have already been able to identify intracellular structural elements, dubbed the “re-entry loop” of iRhom2, that transmit information from the inside of a cell to the outside. They are required for the ADAM17 enzyme to function outside of a cell. Until now, these details have not been well understood. 

Seegar emphasized the human impact. “This work provides a foundation for designing therapies targeting ADAM17-related diseases, offering new strategies to address critical health conditions,” he said.

New research core facility

The ADAM17-iRhom2 Complex contains the first protein structures coming out of UC’s Center for Advanced Structural Biology, established in 2022. 

“We are indebted to UC,” said Seegar. “Our work wouldn’t be possible without this research core facility.”

The cryogenic electron microscopy technology being used has transformed structural biology. The center’s focal point is its transmission electron microscope (TEM), which is ideally suited for screening cryo-EM samples and allows researchers to see complex proteins without leaving UC’s campus.

“It’s a privilege to have this microscope in house, and it’s exciting to use it to solve these structures,” said Maciag. “It’s important to our field of cellular biology and will help drive research forward and how we approach our understanding of inflammation in known disease states.”

The Seegar Lab used UC’s Advanced Research Computing Center (ARC) for data processing, allowing them to keep their data, used to create a 3D model of the ADAM17-iRhom2 Complex, on campus as well.

Moving forward, Seegar’s lab plans to research iRhom2 more closely. 

“These adapter proteins are not well understood,” said Slone. “Our research will be in understanding them and will be driven by specificity. Ideally, controlling these will allow researchers to control disease states.”

Other contributors to this study from UC: Igal Ifergan, PhD, assistant professor in the Department of Molecular and Cellular Biosciences in the College of Medicine; Hala Alnajjar, graduate student assistant in the Seegar Lab; Maria Rich, Medical Scientist Training Program (MTSP) student in the Seegar Lab; and Bryce Guion, an undergraduate student in the Seegar Lab.

The study was funded by the National Institute of General Medicine Sciences and with support from a University of Cincinnati Research Innovation/Pilot Grant.

Journal

Proceedings of the National Academy of Sciences

Method of Research

Observational study

Subject of Research

Cells

Article Title

Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex

Article Publication Date

13-Jun-2025

Media Contact

Megan Burgasser

University of Cincinnati

megan.burgasser@uc.edu

Cell: 5135455616

Journal
Proceedings of the National Academy of Sciences
Funder

National Institute of General Medical Sciences,
University of Cincinnati

Journal

Proceedings of the National Academy of Sciences

Method of Research

Observational study

Subject of Research

Cells

Article Title

Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex

Article Publication Date

13-Jun-2025

Keywords
/Life sciences/Biochemistry/Biomolecules/Biomolecular structure

/Life sciences/Molecular biology

/Life sciences/Biochemistry/Structural biology

bu içeriği en az 2000 kelime olacak şekilde ve alt başlıklar ve madde içermiyecek şekilde ünlü bir science magazine için İngilizce olarak yeniden yaz. Teknik açıklamalar içersin ve viral olacak şekilde İngilizce yaz. Haber dışında başka bir şey içermesin. Haber içerisinde en az 12 paragraf ve her bir paragrafta da en az 50 kelime olsun. Cevapta sadece haber olsun. Ayrıca haberi yazdıktan sonra içerikten yararlanarak aşağıdaki başlıkların bilgisi var ise haberin altında doldur. Eğer yoksa bilgisi ilgili kısmı yazma.:
Subject of Research:
Article Title:
News Publication Date:
Web References:
References:
Image Credits:

Keywords

Tags: ADAM17 enzyme studyadvanced structural biology technologycryogenic electron microscopy techniquesinflammatory signaling mechanismsmolecular and cellular biosciencesProceedings of the National Academy of Sciencesprotein structure visualizationscientific discovery in protein interactionsSeegar Lab research publicationstructural biologists collaborationtherapeutics design advancementsUniversity of Cincinnati structural biology research